FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2567743670> ?p ?o ?g. }

• W2567743670 endingPage "845" @default.
• W2567743670 startingPage "831" @default.
• W2567743670 abstract "The aim of this study is to systematically evaluate all available treatment options in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (mCRPC). We systematically searched PubMed, EMBASE, and the Cochrane libraries up to 1 March 2016 for peer-reviewed publications on randomised clinical trials (RCTs). RCTs were included if progression-free survival (PFS), overall survival (OS), quality of life (QoL), or adverse events (AEs) were quantitatively evaluated. We assessed the risk of bias with the Cochrane Collaboration's tool and graded the evidence with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group's approach. We included 25 articles, reporting on 10 unique RCTs describing seven different comparisons. In one RCT, a prolonged OS and PFS (high quality) were found with abiraterone and prednisone compared to placebo plus prednisone. In one RCT, a prolonged OS and PFS (high quality) were found with enzalutamide compared to placebo. In two RCTs, a prolonged OS (high and moderate quality) was found with 223 radium compared to placebo, but its effect on PFS is unknown. In three RCTs, a prolonged OS (moderate quality) was found with sipuleucel-T compared to placebo, but no prolonged PFS (low quality). In one RCT a prolonged PFS (high quality) was found with orteronel compared to placebo, but no prolonged OS (moderate quality). In one RCT, a prolonged OS (moderate quality) was found with bicalutamide compared to placebo, but its effect on PFS is unknown. In one RCT, a prolonged PFS (high quality) was found with enzalutamide compared to bicalutamide, but its effect on OS is unknown. The best evidence was found for abiraterone and enzalutamide for effective prolongation of OS and PFS to treat chemotherapy-naive patients with mCRPC. However, taking both QoL and AEs into consideration, other treatment modalities could be considered for individual patients." @default.
• W2567743670 created "2017-01-13" @default.
• W2567743670 creator A5005238316 @default.
• W2567743670 creator A5022416224 @default.
• W2567743670 creator A5033402992 @default.
• W2567743670 creator A5037691698 @default.
• W2567743670 date "2017-02-28" @default.
• W2567743670 modified "2023-10-05" @default.
• W2567743670 title "First-line non-cytotoxic therapy in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of 10 randomised clinical trials" @default.
• W2567743670 cites W1893347245 @default.
• W2567743670 cites W1913797671 @default.
• W2567743670 cites W1968735621 @default.
• W2567743670 cites W1971322201 @default.
• W2567743670 cites W1985734141 @default.
• W2567743670 cites W2000159285 @default.
• W2567743670 cites W2014145760 @default.
• W2567743670 cites W2018964568 @default.
• W2567743670 cites W2028813021 @default.
• W2567743670 cites W2038735381 @default.
• W2567743670 cites W2045589622 @default.
• W2567743670 cites W2055346449 @default.
• W2567743670 cites W2063322325 @default.
• W2567743670 cites W2064219355 @default.
• W2567743670 cites W2077244514 @default.
• W2567743670 cites W2080439368 @default.
• W2567743670 cites W2085916278 @default.
• W2567743670 cites W2088132910 @default.
• W2567743670 cites W2103090668 @default.
• W2567743670 cites W2103959341 @default.
• W2567743670 cites W2116607127 @default.
• W2567743670 cites W2120292596 @default.
• W2567743670 cites W2123526148 @default.
• W2567743670 cites W2124670562 @default.
• W2567743670 cites W2127307826 @default.
• W2567743670 cites W2129511481 @default.
• W2567743670 cites W2134080318 @default.
• W2567743670 cites W2137467802 @default.
• W2567743670 cites W2140525590 @default.
• W2567743670 cites W2141454098 @default.
• W2567743670 cites W2143214713 @default.
• W2567743670 cites W2143891871 @default.
• W2567743670 cites W2144827656 @default.
• W2567743670 cites W2150418305 @default.
• W2567743670 cites W2151964152 @default.
• W2567743670 cites W2155466895 @default.
• W2567743670 cites W2158639339 @default.
• W2567743670 cites W2165010366 @default.
• W2567743670 cites W2166305340 @default.
• W2567743670 cites W2166918329 @default.
• W2567743670 cites W2169258216 @default.
• W2567743670 cites W2170668585 @default.
• W2567743670 cites W2170731023 @default.
• W2567743670 cites W2239698670 @default.
• W2567743670 cites W2273795158 @default.
• W2567743670 cites W2283896427 @default.
• W2567743670 cites W4294215472 @default.
• W2567743670 doi "https://doi.org/10.1111/bju.13764" @default.
• W2567743670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28063195" @default.
• W2567743670 hasPublicationYear "2017" @default.
• W2567743670 type Work @default.
• W2567743670 sameAs 2567743670 @default.
• W2567743670 citedByCount "13" @default.
• W2567743670 countsByYear W25677436702017 @default.
• W2567743670 countsByYear W25677436702018 @default.
• W2567743670 countsByYear W25677436702019 @default.
• W2567743670 countsByYear W25677436702022 @default.
• W2567743670 crossrefType "journal-article" @default.
• W2567743670 hasAuthorship W2567743670A5005238316 @default.
• W2567743670 hasAuthorship W2567743670A5022416224 @default.
• W2567743670 hasAuthorship W2567743670A5033402992 @default.
• W2567743670 hasAuthorship W2567743670A5037691698 @default.
• W2567743670 hasBestOaLocation W25677436701 @default.
• W2567743670 hasConcept C121608353 @default.
• W2567743670 hasConcept C126322002 @default.
• W2567743670 hasConcept C142724271 @default.
• W2567743670 hasConcept C143998085 @default.
• W2567743670 hasConcept C168563851 @default.
• W2567743670 hasConcept C197934379 @default.
• W2567743670 hasConcept C204787440 @default.
• W2567743670 hasConcept C27081682 @default.
• W2567743670 hasConcept C2775832370 @default.
• W2567743670 hasConcept C2776551883 @default.
• W2567743670 hasConcept C2777899217 @default.
• W2567743670 hasConcept C2778720950 @default.
• W2567743670 hasConcept C2780192828 @default.
• W2567743670 hasConcept C2780962315 @default.
• W2567743670 hasConcept C61367390 @default.
• W2567743670 hasConcept C71924100 @default.
• W2567743670 hasConceptScore W2567743670C121608353 @default.
• W2567743670 hasConceptScore W2567743670C126322002 @default.
• W2567743670 hasConceptScore W2567743670C142724271 @default.
• W2567743670 hasConceptScore W2567743670C143998085 @default.
• W2567743670 hasConceptScore W2567743670C168563851 @default.
• W2567743670 hasConceptScore W2567743670C197934379 @default.
• W2567743670 hasConceptScore W2567743670C204787440 @default.
• W2567743670 hasConceptScore W2567743670C27081682 @default.
• W2567743670 hasConceptScore W2567743670C2775832370 @default.
• W2567743670 hasConceptScore W2567743670C2776551883 @default.

• next